$CLPS
CLPS Inc Stock $clps

$clps Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 20-F Financial Statement

#000121390024088712 Filed on October 18, 2024

Income Statement

Concept	2024 Q3	2024
Revenue		$142.8M
YoY Change		-5.02%
Cost Of Revenue		$109.9M
YoY Change		-5.19%
Gross Profit		$32.95M
YoY Change		-4.45%
Gross Profit Margin		23.07%
Selling, General & Admin		$29.69M
YoY Change		19.05%
% of Gross Profit		90.12%
Research & Development		$7.156M
YoY Change		-14.17%
% of Gross Profit		21.72%
Depreciation & Amortization		$1.252M
YoY Change		2.68%
% of Gross Profit		3.8%
Operating Expenses		$35.49M
YoY Change		3.14%
Operating Profit		-$2.538M
YoY Change		-3422.92%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		$15.86M
YoY Change		-12.01%
Pretax Income		$2.878M
YoY Change		-33.83%
Income Tax		$160.7K
% Of Pretax Income		5.58%
Net Earnings		-$2.330M
YoY Change		-1310.19%
Net Earnings / Revenue		-1.63%
Basic Earnings Per Share		-$0.09
Diluted Earnings Per Share		-$0.09
COMMON SHARES
Basic Shares Outstanding	27.84M shares	25.21M shares
Diluted Shares Outstanding		25.21M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$29.12M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses		$901.6K
Receivables		$38.78M
Other Receivables
Total Short-Term Assets		$78.08M
YoY Change		7.14%
LONG-TERM ASSETS
Property, Plant & Equipment		$21.17M
YoY Change		5.25%
Goodwill		$1.474M
YoY Change
Intangibles		$2.254M
YoY Change		210.44%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$31.95M
YoY Change		42.36%
TOTAL ASSETS
Total Short-Term Assets		$78.08M
Total Long-Term Assets		$31.95M
Total Assets		$110.0M
YoY Change		15.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$949.1K
YoY Change		37.55%
Accrued Expenses
YoY Change
Deferred Revenue		$1.139M
YoY Change		24.01%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$39.80M
YoY Change		51.23%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities		$884.0K
YoY Change		-0.22%
Total Long-Term Liabilities		$884.0K
YoY Change		-0.22%
TOTAL LIABILITIES
Total Short-Term Liabilities		$39.80M
Total Long-Term Liabilities		$884.0K
Total Liabilities		$46.11M
YoY Change		54.68%
SHAREHOLDERS EQUITY
Retained Earnings		-$51.73K
YoY Change		-101.03%
Common Stock		$2.564K
YoY Change		8.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$62.51M
YoY Change
Total Liabilities & Shareholders Equity		$110.0M
YoY Change		15.43%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024
OPERATING ACTIVITIES
Net Income			-$2.330M
YoY Change			-1310.19%
Depreciation, Depletion And Amortization			$1.252M
YoY Change			2.68%
Cash From Operating Activities			$8.925M
YoY Change			-8.04%
INVESTING ACTIVITIES
Capital Expenditures			$2.117M
YoY Change			307.73%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities			-$12.25M
YoY Change			3903.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			$10.19M
YoY Change			-335.99%
NET CHANGE
Cash From Operating Activities			$8.925M
Cash From Investing Activities			-$12.25M
Cash From Financing Activities			$10.19M
Net Change In Cash			$6.839M
YoY Change			75.15%
FREE CASH FLOW
Cash From Operating Activities			$8.925M
Capital Expenditures			$2.117M
Free Cash Flow			$6.808M
YoY Change			-25.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	510462	usd
CY2024	dei	Document Type DocumentType	20-F
CY2024	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-38505
CY2024	dei	Entity Registrant Name EntityRegistrantName	CLPS Incorporation
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	c/o Unit 1000, 10th Floor, Millennium City III
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	370 Kwun Tong Road, Kwun Tong
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Kowloon
CY2024	dei	Entity Address Country EntityAddressCountry	HK
CY2024	dei	Security12b Title Security12bTitle	Common Shares, par value $0.0001
CY2024	dei	Trading Symbol TradingSymbol	CLPS
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27840669	shares
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024	ecd	Insider Trd Policies Proc Adopted Flag InsiderTrdPoliciesProcAdoptedFlag	true
CY2024	dei	Auditor Firm AuditorFirmId	1408
CY2024	dei	Auditor Name AuditorName	Ernst & Young Hua Ming LLP
CY2024	dei	Auditor Location AuditorLocation	Shanghai, the People’s Republic of China
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29116431	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22214029	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	24081	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	87604	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	2100000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38779209	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48515467	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4497578	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1665736	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	78076408	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	72874107	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21168524	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20112305	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2254372	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	726175	usd
CY2024Q2	us-gaap	Goodwill Goodwill	1473899	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2776858	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	815324	usd
CY2024Q2	us-gaap	Long Term Investments LongTermInvestments	613807	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	456598	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	594603	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	252656	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	697047	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	81899	usd
CY2024Q2	us-gaap	Assets Assets	110029816	usd
CY2023Q2	us-gaap	Assets Assets	95319064	usd
CY2024Q2	us-gaap	Debt Current DebtCurrent	23232856	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	10554617	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	949137	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	690035	usd
CY2024Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	799495	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	324021	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2351615	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2503375	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1139001	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	918470	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9941541	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10586239	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1361928	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	712302	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	39795803	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	26313948	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1638243	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	104114	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	378344	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	185382	usd
CY2024Q2	clps	Unrecognized Taxs Benefit UnrecognizedTaxsBenefit	3413850	usd
CY2023Q2	clps	Unrecognized Taxs Benefit UnrecognizedTaxsBenefit	2320918	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	883963	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	885901	usd
CY2024Q2	us-gaap	Liabilities Liabilities	46110203	usd
CY2023Q2	us-gaap	Liabilities Liabilities	29810263	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25640056	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25640056	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23650122	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23650122	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	2564	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2365	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	61351200	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	58183383	usd
CY2024Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	5553104	usd
CY2023Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	5356828	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51728	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5029021	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4345902	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3990594	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	62509238	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	64581003	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	1410375	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	927798	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	63919613	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	65508801	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	110029816	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	95319064	usd
CY2024	us-gaap	Revenues Revenues	142812726	usd
CY2023	us-gaap	Revenues Revenues	150356539	usd
CY2022	us-gaap	Revenues Revenues	152022381	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	109865595	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	115874809	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	111033345	usd
CY2024	us-gaap	Gross Profit GrossProfit	32947131	usd
CY2023	us-gaap	Gross Profit GrossProfit	34481730	usd
CY2022	us-gaap	Gross Profit GrossProfit	40989036	usd
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4573344	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3300555	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4103066	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7155949	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8336999	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7971145	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25120010	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21641317	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23045664	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2382538	usd
CY2024	clps	Subsidies And Other Operating Income SubsidiesAndOtherOperatingIncome	1363757	usd
CY2023	clps	Subsidies And Other Operating Income SubsidiesAndOtherOperatingIncome	1256070	usd
CY2022	clps	Subsidies And Other Operating Income SubsidiesAndOtherOperatingIncome	1536394	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	35485546	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	34405339	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	33583481	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-2538415	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	76391	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	7405555	usd
CY2024	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1251465	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1123612	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	854250	usd
CY2024	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	556415	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	430357	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	575605	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1843365	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	769646	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7684200	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	160725	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	674344	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3045992	usd
CY2024	clps	Share Of Loss In Equity Investees Net Of Tax ShareOfLossInEquityInvesteesNetOfTax	-2004090	usd
CY2023	clps	Share Of Loss In Equity Investees Net Of Tax ShareOfLossInEquityInvesteesNetOfTax	95302	usd
CY2022	clps	Share Of Loss In Equity Investees Net Of Tax ShareOfLossInEquityInvesteesNetOfTax	4638208	usd
CY2024	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	156780	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	70263	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-50297	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-1847310	usd
CY2023	us-gaap	Profit Loss ProfitLoss	165565	usd
CY2022	us-gaap	Profit Loss ProfitLoss	4587911	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	482655	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-26964	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	132483	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2329965	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	192529	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4455428	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-355386	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3532507	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1828542	usd
CY2024	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-78	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-92161	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-48211	usd
CY2024	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-355308	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3440346	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1780331	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2685273	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3247817	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2675097	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-482577	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	119125	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-84272	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2202696	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3366942	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2759369	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25213012	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23153976	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20924683	shares
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25213012	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23153976	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21057063	shares
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	57730695	usd
CY2022	us-gaap	Profit Loss ProfitLoss	4587911	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1828542	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	7184862	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3867	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	121807	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	67800600	usd
CY2023	clps	Cumulative Effect Of Accounting Change CumulativeEffectOfAccountingChange	26664	usd
CY2023	us-gaap	Profit Loss ProfitLoss	165565	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3532507	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	6283	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2478295	usd
CY2023	clps	Dividends Paid To Noncontrolling Interests DividendsPaidToNoncontrollingInterests	207087	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	1175684	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	65508801	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-1847310	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-355386	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	3168016	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	2554508	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	63919613	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-1847310	usd
CY2023	us-gaap	Profit Loss ProfitLoss	165565	usd
CY2022	us-gaap	Profit Loss ProfitLoss	4587911	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	3168016	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2478295	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7184862	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1252493	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1219812	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	912248	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-717679	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	264027	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	245830	usd
CY2024	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1487063	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1070385	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	138479	usd
CY2024	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	156780	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	70263	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-50297	usd
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-38674	usd
CY2024	us-gaap	Provision For Other Losses ProvisionForOtherLosses	589529	usd
CY2023	us-gaap	Provision For Other Losses ProvisionForOtherLosses	-10525	usd
CY2022	us-gaap	Provision For Other Losses ProvisionForOtherLosses	-178010	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-9720	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-19188	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	85326	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	102155	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2382538	usd
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-258262	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7208359	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-454071	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12317416	usd
CY2024	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	308440	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-3457373	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	123268	usd
CY2024	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	26274	usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-27836	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-222553	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	212771	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	346438	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-215853	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-189912	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3850	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	106994	usd
CY2024	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-226575	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	331330	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	260228	usd
CY2024	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-303260	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	148309	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	640057	usd
CY2024	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-19445	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-291087	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-115260	usd
CY2024	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1118578	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-769939	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	174100	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1181396	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1101526	usd
CY2024	clps	Increase Decrease In Unrecognized Tax Benefit IncreaseDecreaseInUnrecognizedTaxBenefit	1092932	usd
CY2023	clps	Increase Decrease In Unrecognized Tax Benefit IncreaseDecreaseInUnrecognizedTaxBenefit	-266276	usd
CY2022	clps	Increase Decrease In Unrecognized Tax Benefit IncreaseDecreaseInUnrecognizedTaxBenefit	1782752	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8925234	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9705951	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3200889	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2117282	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	519282	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20750110	usd
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8521	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	158365	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	552	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	9076	usd
CY2024	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	2358172	usd
CY2022	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	409625	usd
CY2023	clps	Disposition Of Longterm Investment DispositionOfLongtermInvestment	-111066	usd
CY2022	clps	Disposition Of Longterm Investment DispositionOfLongtermInvestment	-786427	usd
CY2023	clps	Disposition Of Subsidiaries DispositionOfSubsidiaries	-13806	usd
CY2024	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1119635	usd
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	14130000	usd
CY2024	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	3219635	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	14130000	usd
CY2022	clps	Payments To Purchases Maturities Of Shortterm Investments Net PaymentsToPurchasesMaturitiesOfShorttermInvestmentsNet	-4159309	usd
CY2024	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	829847	usd
CY2023	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	204211	usd
CY2022	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	15491	usd
CY2024	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	6513930	usd
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	274212	usd
CY2022	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	83651	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12251016	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-306046	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16290683	usd
CY2024	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	44508794	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	23388911	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	21955625	usd
CY2024	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	31761143	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	26325471	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	14484851	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3867	usd
CY2024	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2554508	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1175684	usd
CY2023	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	207087	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10193143	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4319331	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7474641	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-28482	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1175928	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-727242	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6838879	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3904646	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6342395	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22301633	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18396987	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24739382	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29140512	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22301633	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18396987	usd
CY2024	us-gaap	Income Taxes Paid IncomeTaxesPaid	857515	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1619792	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	676179	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	407574	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	365893	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	342144	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29116431	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22214029	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18396987	usd
CY2024Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	24081	usd
CY2023Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	87604	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29140512	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22301633	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18396987	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Use of estimates and assumptions</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing the consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information as of the date of the consolidated financial statements. Significant estimates required to be made by management include, but are not limited to, allowance for expected credit losses, useful lives of property and equipment and intangible assets, goodwill impairment, impairment of long-lived assets and long-term investments, purchase price allocation and fair value of noncontrolling interests for business combinations and asset acquisition, provision for accrued expenses and other current liabilities, valuation allowance of deferred tax assets, provision for uncertain tax positions, incremental borrowing rates for operating lease liabilities, fair value measurements of equity investments without readily determinable fair values, fair value of warrants and fair value of and estimated forfeitures for share-based compensation. Actual results could differ from those estimates.</p>
CY2024	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	500000	cny
CY2023	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	2382538	usd
CY2024Q2	us-gaap	Deposit Contracts Assets DepositContractsAssets	690554	usd
CY2023Q2	us-gaap	Deposit Contracts Assets DepositContractsAssets	691025	usd
CY2024Q2	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	1139001	usd
CY2023Q2	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	918470	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	890099	usd
CY2024	clps	Percentage Of Value Added Tax PercentageOfValueAddedTax	0.06	pure
CY2024	us-gaap	Other Expenses OtherExpenses	15861290	usd
CY2023	us-gaap	Other Expenses OtherExpenses	18025748	usd
CY2022	us-gaap	Other Expenses OtherExpenses	16771118	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.50	pure
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Concentrations and risks</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">- Foreign currency risk</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A majority of the transactions of the Company’s mainland China subsidiaries are denominated in Renminbi (“RMB”) and a significant portion of the Company and its subsidiaries’ assets and liabilities are denominated in RMB. RMB is not freely convertible into foreign currencies. In mainland China, certain foreign exchange transactions are required by law to be transacted only by authorized financial institutions. Remittances in currencies other than RMB by the Company in China must be processed through PBOC or other China foreign exchange regulatory bodies which require certain supporting documentation in order to affect the remittance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7pt; text-align: justify">The functional currency for the Company’s mainland China subsidiaries is RMB, and the financial statements are presented in U.S. dollars. RMB depreciated by 0.2%, 8.3%, and 3.7% in fiscal years 2024, 2023 and 2022, respectively. It is difficult to predict how market forces or mainland China or U.S. government policy may impact the exchange rate between RMB and U.S. dollar in the future. The change in the value of RMB relative to U.S. dollars may affect the Company’s financial results reported in U.S. dollars without giving effect to any underlying changes in its business or results of operations. Currently, majority of the Company’s assets, liabilities, revenues and costs are denominated in RMB.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that the Company needs to convert U.S. dollars into RMB for capital expenditures and working capital and other business purposes, appreciation of RMB against U.S. dollar would have an adverse effect on the RMB amount the Company would receive from the conversion. Conversely, if the Company decides to convert RMB into U.S. dollar for the purpose of making payments for dividends, strategic acquisition or investments or other business purposes, appreciation of U.S. dollar against RMB would have a negative effect on the U.S. dollar amount available to the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">- Concentration of credit risk</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents, account receivables, contract assets, other assets, note receivables, and amounts due from related parties. As of June 30, 2024 and 2023, the Company has $29,140,512 and $22,301,633 in cash and cash equivalents and restricted cash, which is held by financial institutions in mainland China and international financial institutions outside of mainland China. In the event of bankruptcy of one of these financial institutions, the Company may not be able to claim its cash and cash equivalents and restricted cash back in full. As of June 30, 2024, the Company and its subsidiaries had $147,102,483, $10,815,654, $3,479,656, etc., of cash and cash equivalents on deposit at financial institutions in mainland China, Hong Kong, Singapore, etc. As of June 30, 2023, the Company and its subsidiaries had $17,809,090, $2,832,122, $1,289,130, etc., of cash and cash equivalents on deposit at financial institutions in mainland China, Hong Kong, Singapore, etc. The Company continues to monitor the financial strength of the financial institutions. There has been no recent history of default in relation to these financial institutions. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-style: normal; font-weight: normal">- Significant customers</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company conducts credit evaluations on its customers and generally does not require collateral or other security from such customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The top two customers and their affiliates accounted for 16.7% and 10.1% of total revenues during the year ended June 30, 2024. The top two customers and their affiliates accounted for 21.4% and 9.4% of total revenues during the year ended June 30, 2023. The top two customers and their affiliates accounted for 20.6% and 12.2% of total revenues during the year ended June 30, 2022. The top two customers accounted for 14.50% and 9.8% of the Company’s total accounts receivable balance as of June 30, 2024. The top two customers accounted for 32.3% and 4.1% of the Company’s total accounts receivable balance as of June 30, 2023.</p>
CY2024	clps	Percentage Of Foreign Currency PercentageOfForeignCurrency	0.002	pure
CY2023	clps	Percentage Of Foreign Currency PercentageOfForeignCurrency	0.083	pure
CY2022	clps	Percentage Of Foreign Currency PercentageOfForeignCurrency	0.037	pure
CY2024Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	40000	sgd
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	39178089	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	48582555	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	398880	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	67088	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38779209	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48515467	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	67088	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	126372	usd
CY2023	clps	Allowance For Doubtful Accounts Receivable Adoption AllowanceForDoubtfulAccountsReceivableAdoption	13372	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	338878	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11238	usd
CY2024	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	7038	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	15788	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	67599	usd
CY2024	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	48	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	507	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	398880	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	67088	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	901567	usd
CY2024Q2	us-gaap	Deposit Contracts Assets DepositContractsAssets	690554	usd
CY2023Q2	us-gaap	Deposit Contracts Assets DepositContractsAssets	691025	usd
CY2024Q2	us-gaap	Supplies Supplies	968151	usd
CY2023Q2	us-gaap	Supplies Supplies	155179	usd
CY2024Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	726691	usd
CY2023Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	114400	usd
CY2024Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1376357	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	280223	usd
CY2024Q2	clps	Advances To Employees AdvancesToEmployees	408480	usd
CY2023Q2	clps	Advances To Employees AdvancesToEmployees	100090	usd
CY2024Q2	us-gaap	Prepaid Taxes PrepaidTaxes	59647	usd
CY2023Q2	us-gaap	Prepaid Taxes PrepaidTaxes	74329	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	39266	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	7316	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	5092181	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1918392	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	594603	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	252656	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4497578	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1665736	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	7316	usd
CY2023	clps	Allowance For Doubtful Account Adoption Of Asu201613 AllowanceForDoubtfulAccountAdoptionOfASU201613	13292	usd
CY2024	clps	Provisions For Doubtful Accounts ProvisionsForDoubtfulAccounts	31900	usd
CY2023	clps	Recovery Of Doubtful Accounts RecoveryOfDoubtfulAccounts	5976	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	50	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	39266	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	7316	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24744370	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22550672	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3575846	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2438367	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21168524	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20112305	usd
CY2024	us-gaap	Depreciation Depreciation	1036767	usd
CY2023	us-gaap	Depreciation Depreciation	1040734	usd
CY2022	us-gaap	Depreciation Depreciation	709836	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2873693	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	619321	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2254372	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1147333	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	421158	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	726175	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	196859	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	179078	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	202412	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	329929	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	282490	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	236059	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	220406	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	208415	usd
CY2024	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2	pure
CY2024	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1510904	usd
CY2024	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-37005	usd
CY2024Q2	us-gaap	Goodwill Goodwill	1473899	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2382538	usd
CY2024Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	1514162	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1070385	usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	1181396	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1101526	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3553256	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	815324	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M15D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.051	pure
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0554	pure
CY2024	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	578756	usd
CY2024	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	651526	usd
CY2024	us-gaap	Selling Expense SellingExpense	259930	usd
CY2024	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	23950	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	783669	usd
CY2023	us-gaap	Selling Expense SellingExpense	263775	usd
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	55082	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1709211	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1067162	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	442176	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3218549	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	218378	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3000171	usd
CY2024Q2	clps	Lessee Operating Lease Liability Minimum Payments Related To Leases LesseeOperatingLeaseLiabilityMinimumPaymentsRelatedToLeases	264637	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	32744	usd
CY2024Q2	us-gaap	Debt Current DebtCurrent	23232856	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	10554617	usd
CY2024Q2	us-gaap	Weighted Average Interest Rate On Overdrawn Demand Deposit WeightedAverageInterestRateOnOverdrawnDemandDeposit	0.0295	pure
CY2023Q2	us-gaap	Weighted Average Interest Rate On Overdrawn Demand Deposit WeightedAverageInterestRateOnOverdrawnDemandDeposit	0.03467	pure
CY2022Q2	us-gaap	Weighted Average Interest Rate On Overdrawn Demand Deposit WeightedAverageInterestRateOnOverdrawnDemandDeposit	0.03771	pure
CY2024	clps	Loan Principal Due Year LoanPrincipalDueYear	P1Y
CY2024	us-gaap	Labor And Related Expense LaborAndRelatedExpense	975776	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1181491	usd
CY2024	us-gaap	Other Income OtherIncome	61244	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.15	pure
CY2024	clps	Preferential Tax Rate PreferentialTaxRate	0.15	pure
CY2024	clps	Statutory Income Tax Rate StatutoryIncomeTaxRate	0.15	pure
CY2024	clps	Reduced Eit Rate ReducedEITRate	0.15	pure
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2878314	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	4350067	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	17366634	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-4721679	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3580421	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-9682434	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1843365	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	769646	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7684200	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.565	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	1.155	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.258	pure
CY2024	clps	Effective Income Tax Rate Reconciliation Deferred Tax EffectiveIncomeTaxRateReconciliationDeferredTax	-0.089	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Deferred Tax EffectiveIncomeTaxRateReconciliationDeferredTax	0.079	pure
CY2022	clps	Effective Income Tax Rate Reconciliation Deferred Tax EffectiveIncomeTaxRateReconciliationDeferredTax	-0.003	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	0.27	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	0.285	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	0.101	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.016	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.051	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.966	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	2.304	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.18	pure
CY2024	clps	Effective Income Tax Rate Reconciliation Business Insurance EffectiveIncomeTaxRateReconciliationBusinessInsurance	-0.057	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Business Insurance EffectiveIncomeTaxRateReconciliationBusinessInsurance	0.137	pure
CY2022	clps	Effective Income Tax Rate Reconciliation Business Insurance EffectiveIncomeTaxRateReconciliationBusinessInsurance	0.015	pure
CY2024	clps	Effective Income Tax Rate Reconciliation Late Payment Interest EffectiveIncomeTaxRateReconciliationLatePaymentInterest	-0.20	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Late Payment Interest EffectiveIncomeTaxRateReconciliationLatePaymentInterest	0.425	pure
CY2022	clps	Effective Income Tax Rate Reconciliation Late Payment Interest EffectiveIncomeTaxRateReconciliationLatePaymentInterest	0.005	pure
CY2024	clps	Effective Income Tax Rate Reconciliation Withholding Tax EffectiveIncomeTaxRateReconciliationWithholdingTax	-0.047	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Withholding Tax EffectiveIncomeTaxRateReconciliationWithholdingTax	0.091	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	-0.022	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.075	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	0.004	pure
CY2024	clps	Effective Income Tax Rate Reconciliation Investment Gainloss EffectiveIncomeTaxRateReconciliationInvestmentGainloss	-0.023	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Investment Gainloss EffectiveIncomeTaxRateReconciliationInvestmentGainloss	0.432	pure
CY2022	clps	Effective Income Tax Rate Reconciliation Investment Gainloss EffectiveIncomeTaxRateReconciliationInvestmentGainloss	-0.015	pure
CY2024	clps	Effective Income Tax Rate Reconciliation Statutory Incomeexpense EffectiveIncomeTaxRateReconciliationStatutoryIncomeexpense	0.039	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Statutory Incomeexpense EffectiveIncomeTaxRateReconciliationStatutoryIncomeexpense	-0.061	pure
CY2022	clps	Effective Income Tax Rate Reconciliation Statutory Incomeexpense EffectiveIncomeTaxRateReconciliationStatutoryIncomeexpense	-0.014	pure
CY2024	clps	Effective Income Tax Rate Reconciliation Intercompany Transfers EffectiveIncomeTaxRateReconciliationIntercompanyTransfers	-0.109	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Intercompany Transfers EffectiveIncomeTaxRateReconciliationIntercompanyTransfers	-0.247	pure
CY2022	clps	Effective Income Tax Rate Reconciliation Intercompany Transfers EffectiveIncomeTaxRateReconciliationIntercompanyTransfers	0.108	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.036	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.433	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.066	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Goodwill Provision EffectiveIncomeTaxRateReconciliationGoodwillProvision	0.69	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.012	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.058	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.005	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.087	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.877	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.398	pure
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	878404	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	410317	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2800162	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-717679	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	264027	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	245830	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	160725	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	674344	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3045992	usd
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1394349	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	996177	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	27184	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	39516	usd
CY2024Q2	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	641646	usd
CY2023Q2	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	169375	usd
CY2024Q2	clps	Deferred Tax Assets Share Of Investees Loss DeferredTaxAssetsShareOfInvesteesLoss	27125	usd
CY2023Q2	clps	Deferred Tax Assets Share Of Investees Loss DeferredTaxAssetsShareOfInvesteesLoss	27078	usd
CY2024Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	118734	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	28724	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	935005	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1009596	usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1274033	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	251274	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	576986	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	169375	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	378344	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	117781	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	67601	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	955330	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	354757	usd
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	697047	usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	81899	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	378344	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	185382	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	147982	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	70016	usd
CY2023Q2	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	62237	usd
CY2024Q2	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	35439209	usd
CY2023Q2	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	23459996	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2780674	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2442085	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3095554	usd
CY2024Q2	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	2649114	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	1924305	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	2497005	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	21209	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	21256	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	446490	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2442085	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3095554	usd
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1333608	usd
CY2024	clps	Increases In Unrecognized Tax Benefit IncreasesInUnrecognizedTaxBenefit	518179	usd
CY2023	clps	Increases In Unrecognized Tax Benefit IncreasesInUnrecognizedTaxBenefit	934563	usd
CY2022	clps	Increases In Unrecognized Tax Benefit IncreasesInUnrecognizedTaxBenefit	2132154	usd
CY2024	clps	Decrease Unrecognized Tax Benefit DecreaseUnrecognizedTaxBenefit	-172682	usd
CY2023	clps	Decrease Unrecognized Tax Benefit DecreaseUnrecognizedTaxBenefit	-1386797	usd
CY2022	clps	Decrease Unrecognized Tax Benefit DecreaseUnrecognizedTaxBenefit	-267622	usd
CY2024	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-6908	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-201235	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-102586	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2780674	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2442085	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3095554	usd
CY2024Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	761457	usd
CY2023Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	654799	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	146030	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	417445	usd
CY2024Q2	clps	Withholding Tax Payable WithholdingTaxPayable	326183	usd
CY2023Q2	clps	Withholding Tax Payable WithholdingTaxPayable	343753	usd
CY2024Q2	clps	Disability Insurance Fund Payable DisabilityInsuranceFundPayable	1035935	usd
CY2023Q2	clps	Disability Insurance Fund Payable DisabilityInsuranceFundPayable	1011958	usd
CY2024Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	82010	usd
CY2023Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	75420	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2351615	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2503375	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2329965	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	192529	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4455428	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25213012	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23153976	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20924683	shares
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2329965	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	192529	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4455428	usd
CY2024	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	25213012	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	23153976	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	20924683	shares
CY2022	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	132380	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25213012	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23153976	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21057063	shares
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2021Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	2666666	shares
CY2021Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	6
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2666666	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2666666	shares
CY2023Q2	clps	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	2666666	shares
CY2024Q2	clps	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	2666666	shares
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P5Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	1186806	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	1000105	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	1196971	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.42	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.43	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.40	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0442	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.04	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q2	clps	Fair Market Value Per Common Share FairMarketValuePerCommonShare	0.98	usd
CY2023Q2	clps	Fair Market Value Per Common Share FairMarketValuePerCommonShare	1.135	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5225362	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.22
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.08
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y9M18D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	356642	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1535000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.8
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.45
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	41500	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.8
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.57
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	346435	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.41
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.71
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6372427	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.93
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.92
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y3M18D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	175494	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2628115	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.48
CY2024Q2	clps	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercisable Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisableDateFairValue	1.13
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	18727	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5293215	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.06
CY2024Q2	clps	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Vested And Expected To Vest Outstanding Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageVestedAndExpectedToVestOutstandingDateFairValue	0.22
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y3M18D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	125998	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	506804	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y4M13D
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3168016	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2478295	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7184862	usd
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2666666	shares
CY2021Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	15999996	usd
CY2023Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.1
CY2023Q4	us-gaap	Dividends Common Stock DividendsCommonStock	2560000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1180000	usd
CY2024	clps	Appropriation Of Statutory Reserves AppropriationOfStatutoryReserves	196276	usd
CY2023	clps	Appropriation Of Statutory Reserves AppropriationOfStatutoryReserves	284952	usd
CY2022	clps	Appropriation Of Statutory Reserves AppropriationOfStatutoryReserves	857801	usd
CY2024	clps	Statutory Reserve Description StatutoryReserveDescription	In addition, the Company’s subsidiaries incorporated in mainland China are required to annually appropriate 10% of their net income to the statutory reserve prior to payment of any dividends, unless the reserve has reached 50% of their respective registered capital.
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-550248	usd
CY2023	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	-3532507	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-92161	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3990594	usd
CY2024	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	-355386	usd
CY2024	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-78	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4345902	usd
CY2021Q2	clps	Percentage Of Equity Interest PercentageOfEquityInterest	0.5333	pure
CY2021Q2	clps	Purchase Consideration PurchaseConsideration	205711	usd
CY2021Q2	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	121807	usd
CY2023Q2	clps	Percentage Of Equity Interest PercentageOfEquityInterest	0.40	pure
CY2024	us-gaap	Revenues Revenues	142812726	usd
CY2024	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	145351141	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-2538415	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1843365	usd
CY2024	us-gaap	Revenues Revenues	142812726	usd
CY2023	us-gaap	Revenues Revenues	150356539	usd
CY2022	us-gaap	Revenues Revenues	152022381	usd
CY2024	us-gaap	Revenues Revenues	142812726	usd
CY2023	us-gaap	Revenues Revenues	150356539	usd
CY2022	us-gaap	Revenues Revenues	152022381	usd
CY2024	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2023Q2	us-gaap	Goodwill Goodwill		usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	clps	Appropriation Of Statutory Reserve AppropriationOfStatutoryReserve		usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023	clps	Appropriation Of Statutory Reserve AppropriationOfStatutoryReserve		usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024	clps	Appropriation Of Statutory Reserve AppropriationOfStatutoryReserve		usd
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2024	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2024	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2022	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2024	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement		usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2024	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses		usd
CY2022	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses		usd
CY2024	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
CY2023	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
CY2024	clps	Disposition Of Longterm Investment DispositionOfLongtermInvestment		usd
CY2024	clps	Disposition Of Subsidiaries DispositionOfSubsidiaries		usd
CY2022	clps	Disposition Of Subsidiaries DispositionOfSubsidiaries		usd
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2023	clps	Payments To Purchases Maturities Of Shortterm Investments Net PaymentsToPurchasesMaturitiesOfShorttermInvestmentsNet		usd
CY2024	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock		usd
CY2024	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest		usd
CY2022	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest		usd
CY2022Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents		usd
CY2024	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax		usd
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax		usd
CY2024	clps	Allowance For Doubtful Accounts Receivable Adoption AllowanceForDoubtfulAccountsReceivableAdoption		usd
CY2024	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables		usd
CY2024	clps	Allowance For Doubtful Account Adoption Of Asu201613 AllowanceForDoubtfulAccountAdoptionOfASU201613		usd
CY2023	clps	Provisions For Doubtful Accounts ProvisionsForDoubtfulAccounts		usd
CY2024	clps	Recovery Of Doubtful Accounts RecoveryOfDoubtfulAccounts		usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax		usd
CY2023Q2	us-gaap	Goodwill Goodwill		usd
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	58000000	hkd
CY2023	us-gaap	Other Income OtherIncome		usd
CY2022	us-gaap	Other Income OtherIncome		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome		pure
CY2022	clps	Effective Income Tax Rate Reconciliation Withholding Tax EffectiveIncomeTaxRateReconciliationWithholdingTax		pure
CY2024	clps	Effective Income Tax Rate Reconciliation Goodwill Provision EffectiveIncomeTaxRateReconciliationGoodwillProvision		pure
CY2022	clps	Effective Income Tax Rate Reconciliation Goodwill Provision EffectiveIncomeTaxRateReconciliationGoodwillProvision		pure
CY2024Q2	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities		usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent		usd
CY2024Q2	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries		usd
CY2024	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2024	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2024	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock		shares
CY2023	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock		shares
CY2024	clps	Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted		usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2024	clps	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations Aggregate Intrinsic Value Forfeited Or Expired ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsAggregateIntrinsicValueForfeitedOrExpired		usd
CY2024	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax		usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax		usd
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	00000
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001724542
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd

Files In Submission

Name	View Source	Status
0001213900-24-088712-index-headers.html	Edgar Link	pending
0001213900-24-088712-index.html	Edgar Link	pending
0001213900-24-088712.txt	Edgar Link	pending
0001213900-24-088712-xbrl.zip	Edgar Link	pending
clps-20240630.xsd	Edgar Link	pending
ea0216919-20f_clpsinc.htm	Edgar Link	pending
ea021691901ex10-10_clpsinc.htm	Edgar Link	pending
ea021691901ex10-11_clpsinc.htm	Edgar Link	pending
ea021691901ex10-12_clpsinc.htm	Edgar Link	pending
ea021691901ex10-17_clpsinc.htm	Edgar Link	pending
ea021691901ex10-18_clpsinc.htm	Edgar Link	pending
ea021691901ex10-19_clpsinc.htm	Edgar Link	pending
ea021691901ex10-20_clpsinc.htm	Edgar Link	pending
ea021691901ex10-21_clpsinc.htm	Edgar Link	pending
ea021691901ex10-22_clpsinc.htm	Edgar Link	pending
ea021691901ex10-23_clpsinc.htm	Edgar Link	pending
ea021691901ex10-24_clpsinc.htm	Edgar Link	pending
ea021691901ex10-25_clpsinc.htm	Edgar Link	pending
ea021691901ex10-26_clpsinc.htm	Edgar Link	pending
ea021691901ex10-8_clpsinc.htm	Edgar Link	pending
ea021691901ex10-9_clpsinc.htm	Edgar Link	pending
ea021691901ex11-1_clpsinc.htm	Edgar Link	pending
ea021691901ex12-1_clpsinc.htm	Edgar Link	pending
ea021691901ex12-2_clpsinc.htm	Edgar Link	pending
ea021691901ex13-1_clpsinc.htm	Edgar Link	pending
clps-20240630_cal.xml	Edgar Link	unprocessable
clps-20240630_def.xml	Edgar Link	unprocessable
clps-20240630_lab.xml	Edgar Link	unprocessable
ea0216919-20f_clpsinc_htm.xml	Edgar Link	completed
ea021691901ex21-1_clpsinc.htm	Edgar Link	pending
ea021691901ex23-1_clpsinc.htm	Edgar Link	pending
ea021691901ex97-1_clpsinc.htm	Edgar Link	pending
ex10-10_001.jpg	Edgar Link	pending
ex10-10_002.jpg	Edgar Link	pending
ex10-10_003.jpg	Edgar Link	pending
ex10-17_001.jpg	Edgar Link	pending
ex10-17_002.jpg	Edgar Link	pending
ex10-18_001.jpg	Edgar Link	pending
ex10-18_002.jpg	Edgar Link	pending
ex10-19_001.jpg	Edgar Link	pending
ex10-19_002.jpg	Edgar Link	pending
ex10-23_001.jpg	Edgar Link	pending
ex10-23_002.jpg	Edgar Link	pending
ex10-23_003.jpg	Edgar Link	pending
ex10-23_004.jpg	Edgar Link	pending
ex10-24_001.jpg	Edgar Link	pending
ex10-24_002.jpg	Edgar Link	pending
ex10-24_003.jpg	Edgar Link	pending
ex10-24_004.jpg	Edgar Link	pending
ex11-1_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
clps-20240630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLPS
CLPS Inc Stock $clps

2024 Q3 Form 20-F Financial Statement

#000121390024088712 Filed on October 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLPS CLPS Inc Stock $clps

2024 Q3 Form 20-F Financial Statement

#000121390024088712 Filed on October 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLPS
CLPS Inc Stock $clps